Cellphire Therapeutics, Inc. is a biopharmaceutical company based in Rockville, Maryland, specializing in the development of innovative therapeutics. The organization is utilizing its unique cell preservation technology for all types of cells, including platelets, to create life-preserving treatments. Their flagship product, Thrombosomes®, a dehydrated hemostatic agent sourced from human platelets, is presently undergoing Phase I clinical testing. The technology developed by Cellphire holds potential for diverse medical uses, spanning from trauma to wound care, imaging, and targeted applications.